DK540689A - 1,4-diazepinderivater og deres farmaceutiske anvendelse - Google Patents

1,4-diazepinderivater og deres farmaceutiske anvendelse

Info

Publication number
DK540689A
DK540689A DK540689A DK540689A DK540689A DK 540689 A DK540689 A DK 540689A DK 540689 A DK540689 A DK 540689A DK 540689 A DK540689 A DK 540689A DK 540689 A DK540689 A DK 540689A
Authority
DK
Denmark
Prior art keywords
hydrogen
pharmaceutical use
diazepine derivatives
alkyl
diazepine
Prior art date
Application number
DK540689A
Other languages
Danish (da)
English (en)
Other versions
DK540689D0 (da
Inventor
Kazuo Okano
Shuhei Miyazawa
Richard Stephen John Clark
Shinya Abe
Tetsuya Kawahara
Naoyuki Shimomura
Osamu Asano
Hiroyuki Yoshimura
Mitsuaki Miyamoto
Yoshinori Sakuma
Kenzo Muramoto
Hiroshi Obaishi
Koukichi Harada
Hajime Tsunoda
Satoshi Katayama
Kouji Yamada
Shigeru Souda
Yoshimasa Machida
M Fl K Katayama
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK540689D0 publication Critical patent/DK540689D0/da
Publication of DK540689A publication Critical patent/DK540689A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK540689A 1988-10-31 1989-10-30 1,4-diazepinderivater og deres farmaceutiske anvendelse DK540689A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP27546088 1988-10-31
JP29706888 1988-11-24
JP31801688 1988-12-16
JP33162288 1988-12-28

Publications (2)

Publication Number Publication Date
DK540689D0 DK540689D0 (da) 1989-10-30
DK540689A true DK540689A (da) 1990-05-01

Family

ID=27479049

Family Applications (1)

Application Number Title Priority Date Filing Date
DK540689A DK540689A (da) 1988-10-31 1989-10-30 1,4-diazepinderivater og deres farmaceutiske anvendelse

Country Status (15)

Country Link
EP (3) EP0677524B1 (no)
JP (1) JP2756004B2 (no)
KR (1) KR910009332B1 (no)
CN (1) CN1036520C (no)
AT (3) ATE183187T1 (no)
AU (1) AU621413B2 (no)
CA (1) CA2000985C (no)
DE (3) DE68929372T2 (no)
DK (1) DK540689A (no)
FI (1) FI95708C (no)
HU (1) HU217127B (no)
NO (1) NO175259C (no)
NZ (1) NZ231188A (no)
PH (1) PH27461A (no)
PT (1) PT92153B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
GB8907257D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-paf and anti-ischemic agents
AT394563B (de) * 1990-05-09 1992-05-11 Scras Verfahren zur herstellung von thieno-triazolodiazepinderivaten
DE4027470A1 (de) * 1990-08-30 1992-03-05 Boehringer Ingelheim Kg Neue hetrazepinoide amide
DE4107521A1 (de) * 1991-03-08 1992-09-10 Boehringer Ingelheim Kg Neue acylaminosubstituierte hetrazepine
US5686479A (en) * 1991-12-11 1997-11-11 Yoshitomi Pharmaceutical Industries, Ltd. Immunosuppressive drug
TW219935B (no) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
ES2152952T3 (es) 1992-07-13 2001-02-16 Millennium Pharm Inc 2,5-diaril tetrahidro-tiofenos, -furanos y analogos para el tratamiento de problemas inflamatorios e inmunes.
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
JP2523259B2 (ja) * 1993-06-30 1996-08-07 エスオーエンジニアリング株式会社 フォ―ハ―ス内のガラス温度制御方法
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
EP0995752A4 (en) * 1997-06-25 2001-08-16 Nikken Chemicals Co Ltd TRIAZOLO-1,4-DIAZEPINE COMPOUNDS AND MEDICINAL COMPOSITION CONTAINING THEM
FR2779652B1 (fr) * 1998-06-15 2001-06-08 Sod Conseils Rech Applic Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
US7738074B2 (en) 2003-07-16 2010-06-15 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
US7977336B2 (en) 2006-12-28 2011-07-12 Banyu Pharmaceutical Co. Ltd Aminopyrimidine derivatives as PLK1 inhibitors
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
JP6682522B2 (ja) 2014-06-20 2020-04-15 コンステレーション・ファーマシューティカルズ・インコーポレイテッドＣｏｎｓｔｅｌｌａｔｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． ２−（（４ｓ）−６−（４−クロロフェニル）−１−メチル−４ｈ−ベンゾ［ｃ］イソオキサゾロ［４，５−ｅ］アゼピン−４−イル）アセトアミドの結晶形態

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3778559D1 (de) 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
PH30676A (en) 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
DE3724031A1 (de) 1986-07-22 1988-01-28 Boehringer Ingelheim Kg Neue hetrazepine und verfahren zu ihrer herstellung
ES2039408T3 (es) * 1986-11-17 1993-10-01 Yoshitomi Pharmaceutical Industries, Ltd. Un procedimiento para preparar un compuesto de tienotriazolodiazepina.
EP0368175A1 (de) * 1988-11-06 1990-05-16 Boehringer Ingelheim Kg 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
GB8911030D0 (en) * 1989-05-13 1989-06-28 Scras Hetrazepine derivatives
YU133090A (sh) * 1989-07-12 1993-10-20 Boehringer Ingelheim Kg. Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo
AT394563B (de) * 1990-05-09 1992-05-11 Scras Verfahren zur herstellung von thieno-triazolodiazepinderivaten

Also Published As

Publication number Publication date
EP0677524B1 (en) 2002-02-13
FI894867A0 (fi) 1989-10-13
NO175259B (no) 1994-06-13
HUT53106A (en) 1990-09-28
DE68929049D1 (de) 1999-09-16
DE68929455T2 (de) 2004-01-08
CA2000985C (en) 2000-01-18
PT92153B (pt) 1995-06-30
DE68929049T2 (de) 2000-01-27
FI95708C (fi) 1996-03-11
EP0606103B1 (en) 2003-03-12
EP0367110B1 (en) 1999-08-11
NZ231188A (en) 1991-06-25
ATE213247T1 (de) 2002-02-15
PH27461A (en) 1993-07-09
ATE234306T1 (de) 2003-03-15
HU895609D0 (en) 1990-01-28
DE68929455D1 (de) 2003-04-17
EP0677524A1 (en) 1995-10-18
DE68929372D1 (de) 2002-03-21
NO175259C (no) 1994-09-21
CN1121076A (zh) 1996-04-24
EP0367110A1 (en) 1990-05-09
FI95708B (fi) 1995-11-30
DE68929372T2 (de) 2002-10-02
KR910009332B1 (ko) 1991-11-11
AU621413B2 (en) 1992-03-12
DK540689D0 (da) 1989-10-30
PT92153A (pt) 1990-05-31
JPH02256682A (ja) 1990-10-17
ATE183187T1 (de) 1999-08-15
KR900006342A (ko) 1990-05-08
NO894287D0 (no) 1989-10-27
CA2000985A1 (en) 1990-04-30
NO894287L (no) 1990-05-02
AU4376189A (en) 1990-05-03
EP0606103A1 (en) 1994-07-13
CN1036520C (zh) 1997-11-26
HU217127B (hu) 1999-11-29
JP2756004B2 (ja) 1998-05-25

Similar Documents

Publication Publication Date Title
DK540689D0 (da) 1,4-diazepinderivater og deres farmaceutiske anvendelse
HUP0104364A2 (hu) Pirrolidinszármazékok, CCR-3 receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
DK0626968T3 (da) Thiacykliske piperidinylderivater
ES2072536T3 (es) Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.
DK0643701T3 (da) Benzimidazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse inden for det terapeutiske og kosmetiske område
DE69122812D1 (de) Glutathionderivat
DK1155012T3 (da) Dihydroquinazolinderivater med anti-cancer-aktivitet
DE68906965D1 (de) Analgetische phenothiazinderivate.
DE3769284D1 (de) Fungizide cyclohexylamine.
IT1213219B (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
ATE131172T1 (de) Heterocyclische nmda antagonisten.
DK283189A (da) Phenothiazinderivater, deres fremstilling og farmaceutiske praeparater deraf
DE68918240D1 (de) 1,4-Dihydropyridin-Derivate.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment